Patient characteristics pre and post-implementation of an
antifungal risk-based algorithm
There were no significant differences in sex, race, ethnicity, or cancer
diagnosis between patients diagnosed before or after algorithm
implementation, nor did we observe any change in patterns of IMI timing
(in first remission vs. relapse, age at IMI diagnosis, Table
1 ). Host and clinical risk factors known to be associated with risk for
IMI were also largely unchanged between the two time periods
(Table 3 ), except that patients treated more recently were more
likely to be admitted to the intensive care unit (p=0.003).